A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations
出版年份 2011 全文链接
标题
A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume 13, Issue 8, Pages 677-684
出版商
Wiley
发表日期
2011-03-17
DOI
10.1111/j.1463-1326.2011.01395.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Insulin Pump Therapy in Patients with Type 2 Diabetes Safely Improved Glycemic Control Using a Simple Insulin Dosing Regimen
- (2010) Steven V. Edelman et al. Diabetes Technology & Therapeutics
- Growth hormone, the insulin-like growth factor axis, insulin and cancer risk
- (2010) Peter E. Clayton et al. Nature Reviews Endocrinology
- In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
- (2010) Mark R. Sommerfeld et al. PLoS One
- Treat early, treat appropriately
- (2010) Andreas Liebl et al. Primary Care Diabetes
- Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes
- (2009) Marcus Hompesch et al. CURRENT MEDICAL RESEARCH AND OPINION
- Biphasic Insulin Aspart 30/70: Pharmacokinetics and Pharmacodynamics Compared With Once-Daily Biphasic Human Insulin and Basal-Bolus Therapy
- (2009) T. Heise et al. DIABETES CARE
- Obesity does not influence the unique pharmacological properties of different biphasic insulin aspart preparations in patients with type 2 diabetes
- (2009) T. Parkner et al. DIABETES OBESITY & METABOLISM
- Combined randomised controlled trial experience of malignancies in studies using insulin glargine
- (2009) P. D. Home et al. DIABETOLOGIA
- Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study
- (2009) J. Rosenstock et al. DIABETOLOGIA
- Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden
- (2009) J. M. Jonasson et al. DIABETOLOGIA
- No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis
- (2009) A. Dejgaard et al. DIABETOLOGIA
- Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
- (2009) H. M. Colhoun et al. DIABETOLOGIA
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- (2009) C. J. Currie et al. DIABETOLOGIA
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
- (2009) L. G. Hemkens et al. DIABETOLOGIA
- The rapid-acting properties of insulin aspart are preserved in elderly people with type 2 diabetes*
- (2008) R. Krones et al. DIABETES OBESITY & METABOLISM
- Insulin analogues: an example of applied medical science
- (2008) B. Sheldon et al. DIABETES OBESITY & METABOLISM
- A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period
- (2008) Stephen Luzio et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The Pharmacokinetic and Pharmacodynamic Properties of Different Formulations of Biphasic Insulin Aspart: A Randomized, Glucose Clamp, Crossover Study
- (2008) T. Heise et al. Diabetes Technology & Therapeutics
- Absorption kinetics of insulin after subcutaneous administration
- (2008) Tue Søeborg et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started